Who are Allogeneic cord blood platelet gel-CBPG's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): GrafixPL PRIME.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/allogeneic-cord-blood-platelet-gel-cbpg.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Allogeneic cord blood platelet gel-CBPG — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Allogeneic cord blood platelet gel-CBPG (Allogeneic cord blood platelet gel-CBPG) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Biological wound healing product. Area: Wound Care / Regenerative Medicine.

phase 3 Biological wound healing product Wound Care / Regenerative Medicine Biologic Live · refreshed every 30 min

Target snapshot

Allogeneic cord blood platelet gel-CBPG (Allogeneic cord blood platelet gel-CBPG) — Centro Nazionale Sangue. Allogeneic cord blood platelet gel provides a biological scaffold enriched with growth factors and cytokines from cord blood-derived platelets to promote wound healing and tissue regeneration.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Allogeneic cord blood platelet gel-CBPG TARGET	Allogeneic cord blood platelet gel-CBPG	Centro Nazionale Sangue	phase 3	Biological wound healing product
GrafixPL PRIME	GrafixPL PRIME	University of Texas Southwestern Medical Center	marketed	Biological wound healing product / Placental tissue allograft

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Biological wound healing product class)

Centro Nazionale Sangue · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Allogeneic cord blood platelet gel-CBPG — Competitive Intelligence Brief. https://druglandscape.com/ci/allogeneic-cord-blood-platelet-gel-cbpg. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab